Provenance du réseau au premier degré de Michael Bergamini
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
5
| Public Company | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael Bergamini via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIO-RAD LABORATORIES, INC. | Medical Specialties | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VARIAN MEDICAL SYSTEMS, INC. | Medical Specialties | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| PROBI AB | Biotechnology | Director/Board Member | |
Parion Sciences, Inc.
 Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| EVOLUS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member | |
Severomoravske Vodovody a Kanalizace Ostrava as
 Severomoravske Vodovody a Kanalizace Ostrava as Water UtilitiesUtilities Severomoravske Vodovody a Kanalizace Ostrava AS engages in the production and supply of drinking water. It also deals with the discharge and treatment of wastewater. The company was founded on April 30, 1992 and is headquartered in Ostrava, Czech Republic. | Water Utilities | Director/Board Member | |
| University of California, Los Angeles | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of Illinois | College/University | Undergraduate Degree | |
| University of Uppsala | College/University | Graduate Degree | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Chairman | |
| Keck Graduate Institute of Applied Life Sciences | College/University | Director/Board Member | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
| ACUCELA INC | Pharmaceuticals: Major | Director/Board Member | |
Foundation Fighting Blindness Clinical Research Institute
 Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Financial Conglomerates | Director/Board Member | |
| Licensing Executives Society | Corporate Officer/Principal | ||
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Chairman | |
| Glaxo Group Research Ltd. | General Counsel | ||
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chairman | |
| EXINI DIAGNOSTICS AB | Packaged Software | Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member | |
Glenwood Ventures
 Glenwood Ventures Investment ManagersFinance Glenwood Ventures is a commercial real estate investment firm that specializes in acquiring and developing various types of real estate assets, including industrial, office, life science, residential, and mixed-use properties. Glenwood Ventures was founded in 1900 and is based in Menlo Park, CA. The private company's team members have extensive experience in maximizing real estate value by identifying opportunities and operating assets for their clients and partners. | Investment Managers | Corporate Officer/Principal | |
| NEOS AB | Medical Specialties | Director/Board Member | |
| Wingfirm Pharma AB | Director/Board Member | ||
| The University of North Carolina at Charlotte | College/University | Doctorate Degree | |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Corporate Officer/Principal | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| Jettesta AB | Director/Board Member | ||
| FFB Clinical Research Institute | Director/Board Member | ||
| NANEXA AB | Medical Specialties | Director/Board Member | |
| ADDLIFE AB | Medical/Nursing Services | Director/Board Member | |
| Navigation Dynamics AB | Director/Board Member | ||
Aiviva Biopharma, Inc.
 Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
| Astra Research Centre AB | Chief Tech/Sci/R&D Officer | ||
| Parke-Davis AB | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 28 |
| Suède | 20 |
| Royaume-Uni | 3 |
| République Tchèque | 2 |
| Norvège | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 8 |
| Finance | 5 |
| Commercial Services | 3 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 36 |
| Corporate Officer/Principal | 13 |
| Independent Dir/Board Member | 9 |
| Chairman | 6 |
| Chief Tech/Sci/R&D Officer | 6 |
Relations les plus connectées
| Insiders | |
|---|---|
| Birgit Stattin Norinder | 29 |
| Les Kaplan | 14 |
| Lauren Silvernail | 14 |
| Tomas Navratil | 8 |
| Philippe Masquida | 1 |
- Bourse
- Insiders
- Michael Bergamini
- Connexions Sociétés
